August 22, 2019
Glenmark Pharmaceuticals Inc. is recalling more than 30,000 tubes of clotrimazole and betamethasone dipropionate cream after customers complained of a liquidy texture, according to the August 21, 2019, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 15-gram tubes of clotrimazole and betamethasone dipropionate cream, 1%/0.05% (NDC 68462-298-17), from lot 05180734 (Exp. 3/20). The tubes were distributed throughout the United States.
Glenmark Pharmaceuticals voluntarily initiated the recall August 7, 2019. On August 15, 2019, the FDA designated the recall Class III, suggesting use of the affected cream is not likely to cause harm.
Clotrimazole and betamethasone dipropionate cream is available with a prescription for the treatment of fungal infections.